IPAR vs. PBH, EPC, HLF, USNA, NUS, NATR, MED, REV, VERU, and EL
Should you be buying Inter Parfums stock or one of its competitors? The main competitors of Inter Parfums include Prestige Consumer Healthcare (PBH), Edgewell Personal Care (EPC), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Revlon (REV), Veru (VERU), and Estée Lauder Companies (EL).
Inter Parfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, community ranking, risk, analyst recommendations, media sentiment, earnings and profitability.
In the previous week, Prestige Consumer Healthcare had 10 more articles in the media than Inter Parfums. MarketBeat recorded 14 mentions for Prestige Consumer Healthcare and 4 mentions for Inter Parfums. Inter Parfums' average media sentiment score of 0.95 beat Prestige Consumer Healthcare's score of 0.27 indicating that Inter Parfums is being referred to more favorably in the media.
Inter Parfums presently has a consensus price target of $178.67, suggesting a potential upside of 53.36%. Prestige Consumer Healthcare has a consensus price target of $91.25, suggesting a potential upside of 39.44%. Given Inter Parfums' stronger consensus rating and higher probable upside, equities research analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.
Prestige Consumer Healthcare has lower revenue, but higher earnings than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.
55.6% of Inter Parfums shares are held by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 43.9% of Inter Parfums shares are held by insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Prestige Consumer Healthcare has a net margin of 18.60% compared to Inter Parfums' net margin of 10.50%. Inter Parfums' return on equity of 15.85% beat Prestige Consumer Healthcare's return on equity.
Inter Parfums has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.
Prestige Consumer Healthcare received 38 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.70% of users gave Prestige Consumer Healthcare an outperform vote while only 64.22% of users gave Inter Parfums an outperform vote.
Summary
Inter Parfums beats Prestige Consumer Healthcare on 11 of the 18 factors compared between the two stocks.
Get Inter Parfums News Delivered to You Automatically
Sign up to receive the latest news and ratings for IPAR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IPAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inter Parfums Competitors List
Related Companies and Tools
